THTu Hong

Tu Hong

*This is an algorithmically generated author record based on publicly available information.

Tu Hong has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • Ding Peijiao

    Chongqing Co-core Intelligent Technology Research Institute Co. Ltd. , Chongqing, 400000 China

    1 shared publication
  • Hua Zhu

    Department of Gastroenterology, Yancheng Third People's Hospital, Yancheng, China

    1 shared publication
  • Jiateng Zhang

    Zhejiang University School of Medicine, Hangzhou, China

    1 shared publication
  • Li Chengping

    Chongqing Co-core Intelligent Technology Research Institute Co. Ltd. , Chongqing, 400000 China

    1 shared publication
  • Ma Xiaoyua

    Chongqing Co-core Intelligent Technology Research Institute Co. Ltd. , Chongqing, 400000 China

    1 shared publication
  • Shuang Liu

    School of Optoelectronic Science and Engineering, University of Electronic Science and Technology of China, Chengdu, 611731 China

    1 shared publication

Latest Publications

  • Compound-Axis Tracking System Based on Single-detector Dual-channel Parallel Control

    by Yang Qilong, Ma Xiaoyua, Liu Shuang, Ding Peijiao, Tu Hong, Yuan Guangfu, Li Chengping

    We control two tilt mirrors through the dual-channel parallel control algorithm to achieve Compound-axis tracking, achieving the dynamic range and tracking bandwidth of two-stage compound-axis tracking.

  • Open Access

    Recent advances of eosinophils and its correlated diseases

    by Zhang Tao, Hua Zhu, Jiateng Zhang, Zhiming Huang, Ze Xiang, Tu Hong

    Eosinophils are differentiated by bone marrow multipotent progenitor cells and are further released into peripheral blood after maturation. Human eosinophils can exhibit unique multi-leaf nuclear morphology, which are filled with cytoplasmic granules that contain cytotoxicity and immune regulatory proteins. In recent years, many studies focused on the origin, differentiation and development process of eosinophils. It has been discovered that the eosinophils have the regulatory functions of innate and adaptive immunity, and can also function in several diseases, including asthma, chronic obstructive pulmonary diseases, acute respiratory distress syndrome, malignant tumors and so on. Hence, the role and effects of eosinophils in various diseases are emphasized. In this review, we comprehensively summarized the development and differentiation process of eosinophils, the research progress of their related cytokines, diseases and current clinical treatment options, and discussed the potential drug target, aiming to provide a theoretical and practical basis for the clinical prevention and treatment of eosinophil-related diseases, especially respiratory diseases. To conclude, the guiding significance of future disease treatment is proposed based on the recent updated understandings into the cell functions of eosinophils.